What experts expect from the Novartis record.
Novartis announced the numbers for the quarter expired on December 31, 2024 on January 31, 2025.
11 analysts expect an average result per share of USD 1.80. This corresponds to a reduction of 50.95 percent compared to the previous year, when CHF 3.67 were generated.
10 analysts go on average of $ 12.84 billion – this would correspond to an increase of 26.67 percent compared to the same period last year. At that time, CHF 10.13 billion had been generated.
The estimates of 23 analysts for the past fiscal year amount to a profit of $ 7.54 per share. In the period of the previous fiscal year, the company was able to earn a profit of CHF 6.43 per share. In sales, 22 analysts assume $ 50.44 billion after 40.83 billion CHF had previously been generated in the period.
Editor finance.net
Selected leverage products on Novartis
With knock-outs, speculative investors can participate disproportionately in price movements. Simply choose the desired lever and we will show you suitable open-end products on Novartis
The lever must be between 2 and 20
Advertising